Development of Crohn's disease following anti-tumour necrosis factor therapy (etanercept)

Colorectal Disease

Volumn 10, Issue 9, 2008, Pages 953-954

  Yazisiz, Veli ^a   Avci, A B ^a   Erbasan, F ^a   Yildirim, B ^a   Terzioglu E ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ETANERCEPT; MESALAZINE; PREDNISONE; SALAZOSULFAPYRIDINE; STEROID;

ABDOMINAL PAIN; ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CASE REPORT; COLON ULCER; COLONOSCOPY; CROHN DISEASE; DIARRHEA; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; MALE; MUCOSA INFLAMMATION; PRIORITY JOURNAL; RECTUM HEMORRHAGE; RECTUM ULCER; WEIGHT REDUCTION;

ANTIBODIES, MONOCLONAL; CROHN DISEASE; HUMANS; IMMUNOGLOBULIN G; MALE; RECEPTORS, TUMOR NECROSIS FACTOR; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 54949118761     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2008.01490.x     Document Type: Article

References (5)

1. Ruemmele FM, Prieur AM, Talbotec C, Goulet O, Schmitz J. Development of Crohn disease during anti-TNF-alpha therapy in a child with juvenile idiopathic arthritis. J Pediatr Gastroenterol Nutr 2004; 39: 203-6.
2. Oh J, Arkfeld DG, Horwitz DA. Development of Crohn's disease in a patient taking etanercept. J Rheumatol 2005; 32: 752-3.
3. Ahmad K, Rogers S. Two years of experience with etanercept in recalcitrant psoriasis. Br J Dermatol 2007; 156: 1010-4.
4. Tsochatzis E, Vassilopoulos D, Manesis EK et al. First appearance of Crohn's disease following infliximab treatment for spondylarthropathy. Scand J Gastroenterol 2007; 42: 784-5.
5. Van den Brande JM, Braat H, van den Brink GR et al. Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. Gastroenterology 2003; 124: 1774-85.